Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

NCT00120120 is registered in ClinicalTrials.gov with Celgene Corporation as lead sponsor.

NCT NCT00120120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00120120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy
Lead sponsor
Celgene Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2005
Completion date
November 30, 2007
Enrollment
181 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

radiculopathy